Abnova offers monoclonal antibody (Mab) development in mice, rats and rabbits, with guaranteed success based on standard endpoints or customer's specific applications. Our high rate of success, short turn-around time and affordable cost are due to our proprietary hybridoma technology, state-of- the-art, specific pathogen free (SPF) facility, extensive experience in antibody production for over 10,000 gene targets, and flexibility to suit our customer's needs.
|
|
For any inquiry, please contact : OEM@abnova.com